Ironwood Pharmaceuticals Inc. Class A (IRWD) Key Ratios

$4.73

up-down-arrow $0.02 (0.42%)

As on 20-Nov-2026 12:37EST

Market cap

info icon

$800 Mln

Revenue (TTM)

info icon

$400 Mln

P/E Ratio

info icon

5.4

P/B Ratio

info icon

2.6

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue 17.69 9.00 18.09 -2.54 -0.64
EBIT 15.89 22.68 77.51 2.50 2.39
Net Profit 16.66 49.30 424.10 29.31 -22.00
EPS 16.28 59.88 488.94 28.96 -22.58
Book Value -- -- -- -- --
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsTTMDec-25Dec-24
EBIT-Margin info 35.3945.1264.3034.7027.24
Net Margin info --84.7637.38----
Return on equity info -221.23-95.55---8.53-0.27
Return on Capital info -43.87-9.84--7.570.26
Return on Assets info -40.30-8.5031.056.420.21
Debt to Equity (x) info -----3.34-2.28-1.99
ROCE

--

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Ironwood Pharmaceuticals Inc. Class A (IRWD)
--
7.57
0.26
-139.44
16.29
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROE

--

--

Profit after tax / Average Net worth * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Ironwood Pharmaceuticals Inc. Class A (IRWD)
--
-8.53
-0.27
-654.88
27.83
Peer Median
-39.52
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROA

31.05

Higher than Peers by 62.19

Profit after tax / Average Total assets * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Ironwood Pharmaceuticals Inc. Class A (IRWD)
31.05
6.42
0.21
-127.54
15.72
Peer Median
-31.14
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Margin

64.30

Higher than Peers by 124.32

Operating profit (EBIT) / Net Sales * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Ironwood Pharmaceuticals Inc. Class A (IRWD)
64.30
34.70
27.24
44.23
63.33
Peer Median
-60.02
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Margin

37.38

Higher than Peers by 106.25

Net profit / Total Income (Net sales plus other income) * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Ironwood Pharmaceuticals Inc. Class A (IRWD)
37.38
8.11
0.25
-226.37
41.65
Peer Median
-68.87
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Profit Margin

0.00

Higher than Peers by 0.00

(Net profit + Depreciation) / Gross Sales * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Ironwood Pharmaceuticals Inc. Class A (IRWD)
0.00
--
--
--
--
Peer Median
0.00
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Revenue Growth

18.09

Lower than Peers by 36.91

Year on year growth in net sales

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Ironwood Pharmaceuticals Inc. Class A (IRWD)
18.09
-0.16
-0.21
0.08
-0.01
Peer Median
55.00
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Growth

77.51

Higher than Peers by 78.99

Year on year growth in operating profit (EBIT)

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Ironwood Pharmaceuticals Inc. Class A (IRWD)
77.51
7.37
-51.12
-24.68
11.97
Peer Median
-1.47
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Profit Growth

424.10

Higher than Peers by 430.15

Year on year growth in profit after tax

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Ironwood Pharmaceuticals Inc. Class A (IRWD)
424.10
2,629.20
100.09
-672.50
-66.87
Peer Median
-6.05
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EPS Growth

488.94

Higher than Peers by 475.58

Year on year growth in earnings per share

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Ironwood Pharmaceuticals Inc. Class A (IRWD)
488.94
23.63
1.00
-7.80
-0.70
Peer Median
13.36
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Book Value Growth

60.60

Higher than Peers by 68.80

Year on year growth in book value per share

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Ironwood Pharmaceuticals Inc. Class A (IRWD)
60.60
--
--
--
--
Peer Median
-8.20
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Debt to Equity

-3.34

--

Total debt / Net worth

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Ironwood Pharmaceuticals Inc. Class A (IRWD)
-3.34
-2.28
-1.99
-2.07
0.64
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Short term debt to equity ratio

-0.03

--

(Short term borrowings / Net worth)

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Ironwood Pharmaceuticals Inc. Class A (IRWD)
-0.03
-0.78
-0.01
-0.59
0.00
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Current Ratio

6.51

Higher than Peers by 0.71

Current Assets / Current Liabilities and Provisions

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Ironwood Pharmaceuticals Inc. Class A (IRWD)
6.51
1.13
4.69
0.84
30.58
Peer Median
5.80
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Quick Ratio

6.51

Higher than Peers by 0.85

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Ironwood Pharmaceuticals Inc. Class A (IRWD)
6.51
--
--
0.84
30.53
Peer Median
5.65
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Interest Coverage

8.46

Higher than Peers by 10.55

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Ironwood Pharmaceuticals Inc. Class A (IRWD)
8.46
3.14
2.90
9.05
34.22
Peer Median
-2.09
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

33.16

Higher than Peers by 14.28

Debtors outstanding / Net Sales * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Ironwood Pharmaceuticals Inc. Class A (IRWD)
33.16
15.78
23.30
29.16
28.12
Peer Median
18.87
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Asset Turnover

0.83

Higher than Peers by 0.76

Sales / Average Total Assets

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Ironwood Pharmaceuticals Inc. Class A (IRWD)
0.83
0.79
0.86
0.56
0.37
Peer Median
0.07
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Receivable days

--

--

Average Debtors / Sales * 365

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Ironwood Pharmaceuticals Inc. Class A (IRWD)
--
79.32
109.66
100.89
102.08
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Inventory Days

--

--

Average Inventory / Sales * 365

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Ironwood Pharmaceuticals Inc. Class A (IRWD)
--
--
0.00
37.13
321.98
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Payable days

--

--

Average Creditors / Cost of goods sold * 365

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Ironwood Pharmaceuticals Inc. Class A (IRWD)
--
487.87
240.78
246.94
182.63
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Conversion Cycle

--

--

Receivable Days + Inventory Days - Payable Days

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Ironwood Pharmaceuticals Inc. Class A (IRWD)
--
--
-131.12
-108.92
241.43
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Price / Earnings

5.43

--

Current share price divided by earning per share in the last twelve months

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Ironwood Pharmaceuticals Inc. Class A (IRWD)
5.43
24.94
807.56
-1.78
13.11
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Price / Book Value

2.59

Lower than Peers by 1.72

Current share price divided by book value per share in the latest financial year

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Ironwood Pharmaceuticals Inc. Class A (IRWD)
2.59
-2.29
-2.36
-5.15
3.52
Peer Median
4.31
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Dividend Yield

--

--

Dividend per share in the past twelve months divided by current share price

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Ironwood Pharmaceuticals Inc. Class A (IRWD)
--
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EV/EBITDA

4.06

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Ironwood Pharmaceuticals Inc. Class A (IRWD)
4.06
9.38
12.50
12.20
7.86
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Market Cap

800

Higher than Peers by 661

Current Share price multiplied by latest total number of shares outstanding

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Ironwood Pharmaceuticals Inc. Class A (IRWD)
800
--
--
--
--
Peer Median
138
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...